Matthew Doroski
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Microbial Natural Products and Biosynthesis, Pneumocystis jirovecii pneumonia detection and treatment, Tuberculosis Research and Epidemiology, Catalytic C–H Functionalization Methods
Most-Cited Works
- → Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications(2014)131 cited
- → Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections(2012)97 cited
- → Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections(2011)97 cited
- → Synthesis of lemonose derivatives: methyl 4-amino-3-O,4-N-carbonyl-2,4,6-trideoxy-3-C-methyl-α-l-lyxo-pyranoside and its phenyl thioglycoside(2015)7 cited
- → Abstract 3095: The development of CPI as a novel, next-generation DNA-targeting payload for ADCs(2017)1 cited